KAS
AGIO icon

Kemnay Advisory Services’s Agios Pharmaceuticals AGIO Stock Holding History

Kemnay Advisory Services’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.8K Buy
533
+56
+12% +$1.7K ﹤0.01% 751
2026
Q1 		$16.1K Buy
+477
New +$13.5K ﹤0.01% 813

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Kemnay Advisory Services's AGIO Position: Q2 2026 in Review

Kemnay Advisory Services increased its Agios Pharmaceuticals (AGIO) stake by 12% in Q2 2026, buying an estimated $1.7K and bringing the position to 533 shares worth $19.8K. The position accounts for ﹤0.01% of the portfolio, ranked #751.

Kemnay Advisory Services first reported a position in AGIO in Q1 2026 and has held it in 2 quarters since. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Kemnay Advisory Services held 533 shares of Agios Pharmaceuticals worth $19.8K as of Q2 2026.
  • Kemnay Advisory Services bought 56 Agios Pharmaceuticals shares in Q2 2026, an estimated $1.7K.
  • Agios Pharmaceuticals made up ﹤0.01% of Kemnay Advisory Services's portfolio in Q2 2026, its #751 holding.
  • Kemnay Advisory Services first reported a position in Agios Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Kemnay Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.